What are the effects of the guidelines-recommended treatments of myocardial infarction on the secretion of pro- and anti-inflammatory cytokins in an in vitro murin inflammatory model? - 26/03/18
, T. Bochaton 2, 3, A. Paccalet 3, C. Crola-Da-Silva 3, E. Bonnefoy-Cudraz 2, N. Mewton 4, M. Ovize 1, 2, 3Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 2 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Résumé |
Introduction |
The prognosis after a myocardial infarction is now importantly linked to the reperfusion injury, which consists in cellular death due to reperfusion by itself. This ischemia/reperfusion phenomenon is mediated by the inflammatory response to myocardial infarction, mainly through the secretion of pro-inflammatory and anti-inflammatory cytokines by macrophages. Many treatments has been developed to target that inflammatory response, but the effects of standard treatments of the myocardial infarction, as recommended in the guidelines, has never been studied.
Objective |
To examine the effects of standard treatments of the myocardial infarction on the secretion of the most important ischemia/reperfusion cytokines.
Method |
We used a murin macrophage model of inflammation (BMDM) to quantify the secretion of the main cytokines of ischemia/reperfusion (TNF-α, IL-6, IL-1α, IL-1β and IL-10). These macrophages were incubated alone, along with a treatment of each main class given after a myocardial infarction or with an association of pre-hospital phase treatments (aspirine, ticagrelor and unfractionned heparin). Secretion of the different cytokines was quantified using an ELISA testing.
Results |
The standard treatments impact mostly IL-1β, which is known to be the most deleterious cytokine during ischemia/reperfusion. Its secretion is lowered by aspirin, the anti-Gp2b3a abciximab, and unfractionned heparin. The other treatments tested, including the low-weight molecular heparin enoxaparin, have no effect on IL-1β secretion. The standard treatments have only few effects on the secretion of the other cytokins.
Conclusion |
Aspirin, abciximab and unfractionned heparin have an important anti-IL-1β effect, reducing its secretion. This could explain the lack of efficacy of the specific anti-IL-1β treatments during the acute phase of myocardial infarction. These results should be confirmed using an in vivo murin model and a human in vitro model.
Le texte complet de cet article est disponible en PDF.Plan
Vol 10 - N° 2
P. 221-222 - avril 2018 Retour au numéro
Article précédent
- Modulation of endothelial function by pro-inflammatory cytokines involved in chronic inflammatory diseases. Focus on IL-17A, IL-20, IL-23 and IL-9
- P. Totoson, R. Bordy, C. Chrétien, A. Béduneau, D. Wendling, C. Prati, C. Demougeot
- Preoperative white blood cells phenotype is associated with postoperative atrial fibrillation after cardiac surgery
- S. Ortmans, O. Molendi-Coste, L. Pineau, S. Ninni, C. Seunes, A. Coisne, X. Marechal, B. Staels, D. Dombrowicz, D. Montaigne
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?